Stocks · Sector
Healthcare Stocks - Prices & Analysis (1,175)
| Company | Ticker | Price | Mkt cap | P/E | Div yield |
|---|---|---|---|---|---|
| CG Oncology, Inc. | CGON | $74.67 | $6.62B | — | |
| Lantheus Holdings, Inc. | LNTH | $100.97 | $6.59B | 24.2 | — |
| MiniMed Group, Inc. | MMED | $23.29 | $6.55B | — | |
| Hims & Hers Health, Inc. | HIMS | $27.71 | $6.47B | — | |
| Bausch + Lomb Corporation | BLCO | $18.04 | $6.44B | — | |
| Centessa Pharmaceuticals plc | CNTA | $40.50 Jun 29, 2026 | $6.16B | — | |
| Travere Therapeutics, Inc. | TVTX | $65.28 | $6.15B | — | |
| Mirum Pharmaceuticals, Inc. | MIRM | $100.90 | $6.15B | — | |
| Liquidia Corporation | LQDA | $68.66 | $6.15B | 49.0 | — |
| Oruka Therapeutics, Inc. | ORKA | $92.51 | $6.13B | — | |
| Terns Pharmaceuticals, Inc. | TERN | $52.95 May 15, 2026 | $6.12B | — | |
| Kiniksa Pharmaceuticals International, plc | KNSA | $77.91 | $6.08B | 81.2 | — |
| Amneal Pharmaceuticals, Inc. | AMRX | $17.44 | $6.07B | 37.1 | — |
| Dianthus Therapeutics, Inc. | DNTH | $108.10 | $6.05B | — | |
| Cogent Biosciences, Inc. | COGT | $34.76 | $6.03B | — | |
| Teleflex Incorporated | TFX | $138.36 | $5.86B | 0.97% | |
| RadNet, Inc. | RDNT | $73.71 | $5.80B | — | |
| Xenon Pharmaceuticals Inc. | XENE | $59.75 | $5.79B | — | |
| PTC Therapeutics, Inc. | PTCT | $69.30 | $5.78B | — | |
| Ligand Pharmaceuticals Incorporated | LGND | $285.60 | $5.69B | 29.8 | — |
| Erasca, Inc. | ERAS | $16.19 | $5.66B | — | |
| Stevanato Group S.p.A. | STVN | $20.51 | $5.60B | 36.0 | 0.30% |
| CRISPR Therapeutics AG | CRSP | $55.79 | $5.39B | — | |
| Sotera Health Company | SHC | $18.90 | $5.39B | 33.2 | — |
| Merit Medical Systems, Inc. | MMSI | $89.60 | $5.35B | 36.6 | — |
| Grifols, S.A. | GRFS | $7.80 | $5.31B | 10.3 | 3.58% |
| Apellis Pharmaceuticals, Inc. | APLS | $41.03 May 15, 2026 | $5.25B | 38.4 | — |
| Definium Therapeutics, Inc. | DFTX | $38.09 | $5.12B | — | |
| Parabilis Medicines, Inc. | PBLS | $40.42 | $4.99B | — | |
| LifeStance Health Group, Inc. | LFST | $12.73 | $4.86B | 97.9 | — |
| ACADIA Pharmaceuticals Inc. | ACAD | $28.02 | $4.83B | 12.6 | — |
| Waystar Holding Corp. | WAY | $25.07 | $4.81B | 37.4 | — |
| Doximity, Inc. | DOCS | $26.35 | $4.70B | 32.1 | — |
| BillionToOne, Inc. | BLLN | $99.39 | $4.69B | 138.0 | — |
| Celcuity Inc. Common Stock | CELC | $95.70 | $4.68B | — | |
| Haemonetics Corporation | HAE | $102.92 | $4.68B | 49.7 | — |
| Edgewise Therapeutics, Inc. | EWTX | $43.07 | $4.68B | — | |
| Amicus Therapeutics Inc | FOLD | $14.49 Apr 27, 2026 | $4.55B | — | |
| Dyne Therapeutics, Inc. | DYN | $24.28 | $4.53B | — | |
| LivaNova PLC | LIVN | $81.92 | $4.50B | 24.0 | — |
| Concentra Group Holdings Parent, Inc. | CON | $34.47 | $4.40B | 22.2 | 0.72% |
| Envista Holdings Corporation | NVST | $27.28 | $4.38B | 47.9 | — |
| Enliven Therapeutics, Inc. | ELVN | $59.32 | $4.35B | — | |
| Integer Holdings Corporation | ITGR | $126.50 | $4.30B | 34.7 | — |
| Heartflow, Inc. | HTFL | $48.91 | $4.25B | — | |
| ICU Medical, Inc. | ICUI | $167.58 | $4.19B | 138.5 | — |
| Legend Biotech Corporation | LEGN | $21.52 | $4.19B | — | |
| Relay Therapeutics, Inc. | RLAY | $19.04 | $4.17B | — | |
| Indivior Pharmaceuticals, Inc. | INDV | $34.94 | $4.12B | 12.5 | — |
| Veradermics, Incorporated | MANE | $98.51 | $4.12B | — |
CG Oncology, Inc.
Healthcare / Biotechnology
- Market Cap
- $6.62B
- P/E
- unprofitable
Lantheus Holdings, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $6.59B
- P/E
- 24.2
MiniMed Group, Inc.
Healthcare / Medical Instruments & Supplies
- Market Cap
- $6.55B
- P/E
- unprofitable
Hims & Hers Health, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $6.47B
- P/E
- unprofitable
Bausch + Lomb Corporation
Healthcare / Medical Instruments & Supplies
- Market Cap
- $6.44B
- P/E
- unprofitable
Centessa Pharmaceuticals plc
Healthcare / Biotechnology
- Market Cap
- $6.16B
- P/E
- unprofitable
Travere Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $6.15B
- P/E
- unprofitable
Mirum Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $6.15B
- P/E
- unprofitable
Liquidia Corporation
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $6.15B
- P/E
- 49.0
Oruka Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $6.13B
- P/E
- unprofitable
Terns Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $6.12B
- P/E
- unprofitable
Kiniksa Pharmaceuticals International, plc
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $6.08B
- P/E
- 81.2
Amneal Pharmaceuticals, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $6.07B
- P/E
- 37.1
Dianthus Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $6.05B
- P/E
- unprofitable
Cogent Biosciences, Inc.
Healthcare / Biotechnology
- Market Cap
- $6.03B
- P/E
- unprofitable
Teleflex Incorporated
Healthcare / Medical Instruments & Supplies
- Market Cap
- $5.86B
- P/E
- unprofitable
- Dividend Yield
- 0.97%
RadNet, Inc.
Healthcare / Diagnostics & Research
- Market Cap
- $5.80B
- P/E
- unprofitable
Xenon Pharmaceuticals Inc.
Healthcare / Biotechnology
- Market Cap
- $5.79B
- P/E
- unprofitable
PTC Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $5.78B
- P/E
- unprofitable
Ligand Pharmaceuticals Incorporated
Healthcare / Biotechnology
- Market Cap
- $5.69B
- P/E
- 29.8
Erasca, Inc.
Healthcare / Biotechnology
- Market Cap
- $5.66B
- P/E
- unprofitable
Stevanato Group S.p.A.
Healthcare / Medical Instruments & Supplies
- Market Cap
- $5.60B
- P/E
- 36.0
- Dividend Yield
- 0.30%
CRISPR Therapeutics AG
Healthcare / Biotechnology
- Market Cap
- $5.39B
- P/E
- unprofitable
Sotera Health Company
Healthcare / Diagnostics & Research
- Market Cap
- $5.39B
- P/E
- 33.2
Merit Medical Systems, Inc.
Healthcare / Medical Instruments & Supplies
- Market Cap
- $5.35B
- P/E
- 36.6
Grifols, S.A.
Healthcare / Drug Manufacturers - General
- Market Cap
- $5.31B
- P/E
- 10.3
- Dividend Yield
- 3.58%
Apellis Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $5.25B
- P/E
- 38.4
Definium Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $5.12B
- P/E
- unprofitable
Parabilis Medicines, Inc.
Healthcare / Biotechnology
- Market Cap
- $4.99B
- P/E
- unprofitable
LifeStance Health Group, Inc.
Healthcare / Medical Care Facilities
- Market Cap
- $4.86B
- P/E
- 97.9
ACADIA Pharmaceuticals Inc.
Healthcare / Biotechnology
- Market Cap
- $4.83B
- P/E
- 12.6
Waystar Holding Corp.
Healthcare / Health Information Services
- Market Cap
- $4.81B
- P/E
- 37.4
Doximity, Inc.
Healthcare / Health Information Services
- Market Cap
- $4.70B
- P/E
- 32.1
BillionToOne, Inc.
Healthcare / Diagnostics & Research
- Market Cap
- $4.69B
- P/E
- 138.0
Celcuity Inc. Common Stock
Healthcare / Biotechnology
- Market Cap
- $4.68B
- P/E
- unprofitable
Haemonetics Corporation
Healthcare / Medical Devices
- Market Cap
- $4.68B
- P/E
- 49.7
Edgewise Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $4.68B
- P/E
- unprofitable
Amicus Therapeutics Inc
Healthcare / Biotechnology
- Market Cap
- $4.55B
- P/E
- unprofitable
Dyne Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $4.53B
- P/E
- unprofitable
LivaNova PLC
Healthcare / Medical Devices
- Market Cap
- $4.50B
- P/E
- 24.0
Concentra Group Holdings Parent, Inc.
Healthcare / Medical Care Facilities
- Market Cap
- $4.40B
- P/E
- 22.2
- Dividend Yield
- 0.72%
Envista Holdings Corporation
Healthcare / Medical Instruments & Supplies
- Market Cap
- $4.38B
- P/E
- 47.9
Enliven Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $4.35B
- P/E
- unprofitable
Integer Holdings Corporation
Healthcare / Medical Devices
- Market Cap
- $4.30B
- P/E
- 34.7
Heartflow, Inc.
Healthcare / Health Information Services
- Market Cap
- $4.25B
- P/E
- unprofitable
ICU Medical, Inc.
Healthcare / Medical Instruments & Supplies
- Market Cap
- $4.19B
- P/E
- 138.5
Legend Biotech Corporation
Healthcare / Biotechnology
- Market Cap
- $4.19B
- P/E
- unprofitable
Relay Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $4.17B
- P/E
- unprofitable
Indivior Pharmaceuticals, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $4.12B
- P/E
- 12.5
Veradermics, Incorporated
Healthcare / Biotechnology
- Market Cap
- $4.12B
- P/E
- unprofitable
Showing 151–200 of 1,175 · ranked by market capitalization
Where the trailing year was a loss, P/E appears as “unprofitable”; a dash is missing data.